Regeneron CEO on 23andMe & $275m in Margaritaville 6/11/25
Squawk Pod
00:00
Intro
This chapter explores 23andMe's evolution into the pharmaceutical sector and the insights from Regeneron's CEO regarding its acquisition potential. It also highlights a U.S.-China trade deal agreement, an apology from a notable figure, and discusses Jimmy Buffett's financial legacy and related legal matters.
Transcript
Play full episode
